Building an evaluation infrastructure to capture process and progress within a Clinical and Translational Science Awards hub. [PDF]
Padek M +4 more
europepmc +1 more source
Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher +10 more
wiley +1 more source
Measuring the aggregated impact of research: Establishing criteria for coding Translational Science Benefits Model data. [PDF]
Miovsky N +10 more
europepmc +1 more source
Contributions of Pathobiological and Translational Science to Understanding and Managing Ischemic Heart Disease: Progress, Impediments, and Future Directions. [PDF]
Buja LM.
europepmc +1 more source
A community participatory approach to enhancing capacity in patient-centered alcohol research: Bridging translational science and empowering women. [PDF]
Sharma P +8 more
europepmc +1 more source
Leveraging the translational science benefits model to enhance planning and evaluation of impact in CTSA hub-supported research. [PDF]
Molzhon A, Dillon PM, DiazGranados D.
europepmc +1 more source
The role of information science within the clinical translational science ecosystem. [PDF]
Ragon B +22 more
europepmc +1 more source
Correction to “Inflammation Is a Key Risk Factor for Persistent Seizures in Neurocysticercosis”
Annals of Clinical and Translational Neurology, EarlyView.
wiley +1 more source

